p53 dimers associate with a head-to-tail response element to repress cyclin B transcription

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Lipski, Robert ^a   Lippincott, Daniel J ^a   Durden, Brittany C ^a   Kaplan, Anne R ^a   Keiser, Hilary E ^a   Park, Jung Ho ^a   Levesque, Aime A ^a  

^a UNIVERSITY OF HARTFORD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYSTAUROSPORINE; CYCLIN B; DIMER; DNA; DNA TOPOISOMERASE; FIRTECAN; GLUTARALDEHYDE; IRINOTECAN; PROTEIN P53; SHORT HAIRPIN RNA; TETRAMER;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS; DNA DAMAGE; G2 PHASE CELL CYCLE CHECKPOINT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; MOLECULAR WEIGHT; OLIGOMERIZATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN FUNCTION; S PHASE CELL CYCLE CHECKPOINT; WILD TYPE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CROSS-LINKING REAGENTS; CYCLIN B; DIMERIZATION; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GLUTARAL; HUMANS; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84864667513     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042615     Document Type: Article

References (46)

1. Meek DW, (2004) The p53 response to DNA damage. DNA Repair (Amst) 3(8-9): 1049-1056.
2. Haupt Y, Maya R, Kazaz A, Oren M, (1997) Mdm2 promotes the rapid degradation of p53. Nature 387(6630): 296-299.
3. Kubbutat MH, Jones SN, Vousden KH, (1997) Regulation of p53 stability by Mdm2. Nature 387(6630): 299-303.
4. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, et al. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281(5383): 1674-1677.
5. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, et al. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281(5383): 1677-1679.
6. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, et al. (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287(5459): 1824-1827.
7. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C, (2000) The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 14(3): 289-300.
8. Taylor WR, Stark GR, (2001) Regulation of the G2/M transition by p53. Oncogene 20(15): 1803-1815.
9. Ho J, Benchimol S, (2003) Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ 10(4): 404-408.
10. Yu J, Zhang L, (2005) The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331(3): 851-858.
11. Wu X, Bayle JH, Olson D, Levine AJ, (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7(7A): 1126-1132.
12. Hengstschlager M, Braun K, Soucek T, Miloloza A, Hengstschlager-Ottnad E, (1999) Cyclin-dependent kinases at the G1-S transition of the mammalian cell cycle. Mutat Res 436(1): 1-9.
13. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B, (1999) 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401(6753): 616-620.
14. Laronga C, Yang HY, Neal C, Lee MH, (2000) Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 275(30): 23106-23112.
15. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, et al. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71(4): 587-597.
16. Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, et al. (1999) Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 18(18): 2892-2900.
17. Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schonthal AH, et al. (1999) Mechanisms of G2 arrest in response to overexpression of p53. Mol Biol Cell 10(11): 3607-3622.
18. Innocente SA, Lee JM, (2005) p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription. FEBS Lett 579(5): 1001-1007.
19. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B, (1992) Definition of a consensus binding site for p53. Nat Genet 1(1): 45-49.
20. McLure KG, Lee PW, (1998) How p53 binds DNA as a tetramer. EMBO J 17(12): 3342-3350.
21. Chin PL, Momand J, Pfeifer GP, (1997) In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation. Oncogene 15(1): 87-99.
22. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, et al. (1993) P21 is a universal inhibitor of cyclin kinases. Nature 366(6456): 701-704.
23. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, et al. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54(5): 1169-1174.
24. Johnson RA, Ince TA, Scotto KW, (2001) Transcriptional repression by p53 through direct binding to a novel DNA element. J Biol Chem 276(29): 27716-27720.
25. Levesque AA, Kohn EA, Bresnick E, Eastman A, (2005) Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints. Oncogene 24(23): 3786-3796.
26. Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, et al. (1996) Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci U S A 93(19): 10309-10314.
27. Kohn EA, Ruth ND, Brown MK, Livingstone M, Eastman A, (2002) Abrogation of the S phase DNA damage checkpoint results in S phase progression or premature mitosis depending on the concentration of 7-hydroxystaurosporine and the kinetics of Cdc25C activation. J Biol Chem 277(29): 26553-26564.
28. Stenger JE, Mayr GA, Mann K, Tegtmeyer P, (1992) Formation of stable p53 homotetramers and multiples of tetramers. Mol Carcinog 5(2): 102-106.
29. Itahana Y, Ke H, Zhang Y, (2009) p53 oligomerization is essential for its C-terminal lysine acetylation. J Biol Chem 284(8): 5158-5164.
30. Kitayner M, Rozenberg H, Kessler N, Rabinovich D, Shaulov L, et al. (2006) Structural basis of DNA recognition by p53 tetramers. Mol Cell 22(6): 741-753.
31. Hanson S, Kim E, Deppert W, (2005) Redox factor 1 (ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization. Oncogene 24(9) 1641-1647: 10.1038/sj.onc.1208351.
32. Innocente SA, Abrahamson JL, Cogswell JP, Lee JM, (1999) p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci U S A 96(5): 2147-2152.
33. Tam SW, Belinsky GS, Schlegel R, (1995) Premature expression of cyclin B sensitizes human HT1080 cells to caffeine-induced premature mitosis. J Cell Biochem 59(3): 339-349.
34. Hoffmann TK, Trellakis S, Okulicz K, Schuler P, Greve J, et al. (2011) Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck. Anticancer Res 31(10): 3151-3157.
35. Yin XY, Grove L, Datta NS, Katula K, Long MW, et al. (2001) Inverse regulation of cyclin B1 by c-myc and p53 and induction of tetraploidy by cyclin B1 overexpression. Cancer Res 61(17): 6487-6493.
36. Manni I, Mazzaro G, Gurtner A, Mantovani R, Haugwitz U, et al. (2001) NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J Biol Chem 276(8): 5570-5576.
37. Imbriano C, Gurtner A, Cocchiarella F, Di Agostino S, Basile V, et al. (2005) Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters. Mol Cell Biol 25(9): 3737-3751.
38. Levesque AA, Fanous AA, Poh A, Eastman A, (2008) Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest. Mol Cancer Ther 7(2): 252-262.
39. Menendez D, Inga A, Resnick MA, (2009) The expanding universe of p53 targets. Nat Rev Cancer 9(10): 724-737.
40. Ho WC, Fitzgerald MX, Marmorstein R, (2006) Structure of the p53 core domain dimer bound to DNA. J Biol Chem 281(29): 20494-20502.
41. Weinberg RL, Veprintsev DB, Fersht AR, (2004) Cooperative binding of tetrameric p53 to DNA. J Mol Biol 341(5): 1145-1159.
42. Menendez D, Krysiak O, Inga A, Krysiak B, Resnick MA, et al. (2006) A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Proc Natl Acad Sci U S A 103(5): 1406-1411.
43. Menendez D, Inga A, Snipe J, Krysiak O, Schonfelder G, et al. (2007) A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1. Mol Cell Biol 27(7): 2590-2600.
44. Yan J, Menendez D, Yang XP, Resnick MA, Jetten AM, (2009) A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage. J Biol Chem 284(29): 19280-19289.
45. Atz J, Wagner P, Roemer K, (2000) Function, oligomerization, and conformation of tumor-associated p53 proteins with mutated C-terminus. J Cell Biochem 76(4): 572-584.
46. Krause K, Wasner M, Reinhard W, Haugwitz U, Dohna CL, et al. (2000) The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res. 28(22): 4410-4418.